REQUEST A DEMO
Total
USD $0.00
Search more companies

Super Formulations Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Super Formulations Private Limited Profile Updated: December 03, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Super Formulations Private Limited is an unlisted company, incorporated on 26/07/2004. It has its registered office in the State of Madhya Pradesh, India. Company's corporate identification number (CIN) is U24232MP2004PTC016782 and registration number is 016782. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
16B, 16D &15F Industrial Area Maxi Road,
Ujjain; Madhya Pradesh; Postal Code: 456010

Contact Details: Purchase the Super Formulations Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Super Formulations Private Limited report to view the information.
Registered Capital:
Purchase the Super Formulations Private Limited report to view the information.
Financial Auditors:
Purchase the Super Formulations Private Limited report to view the information.
Incorporation Date:
July 26, 2004
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
15.46%
Company Performance
Financial values in the chart are available after Super Formulations Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
17.68%
Total operating revenue
17.42%
Operating profit (EBIT)
353.55%
EBITDA
293.48%
Net Profit (Loss) for the Period
493.97%
Total Assets
2.93%
Total Equity
252.6%
Operating Profit Margin (ROS)
11.34%
Net Profit Margin
8.56%
Return on Equity (ROE)
22.39%
Debt/Equity
-161.97%
Quick Ratio
0.33%
Cash Ratio
0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?